DEVENS — The parties considering a new 750,000-square-foot pharmaceutical manufacturing facility in one of three locations nationwide still have Devens on their lists.
The company, which is widely suspected to be Bristol-Myers Squibb, but has been code-named “Hummingbird,” had several representatives touring Devens last week, Devens Enterprise Commission Director Peter Lowitt said on May 4.
”Hummingbird is still flying around,” he said.
MassDevelopment Chief of Staff Meg Delorier confirmed that talks are ongoing, but offered few details.
”We’re continuing to provide information,” she said. “So we believe we’re still in the running.”
The company’s interest in Devens was first announced by MassDevelopment in January. The facility would be established on a large parcel of land off Jackson and Patton roads with frontage on both.
Representatives of MassDevelopment have termed the facility “highly desirable” in recent months, both for the benefits to the Devens tax base and the 550 new jobs it would add.
In other developments, Lowitt said preliminary meetings were being held with the party purchasing the old Riggs Gymnasium on Charlestown Road. While he did not disclose the company name, he said it was a light manufacturing/research and development facility.